- Approval Id
- d4cc42f13dca6a53
- Drug Name
- DECONDINE SYRUP
- Product Name
- DECONDINE SYRUP
- Approval Number
- SIN03181P
- Approval Date
- 1989-06-12
- Registrant
- SUNWARD PHARMACEUTICAL PRIVATE LIMITED
- Licence Holder
- SUNWARD PHARMACEUTICAL PRIVATE LIMITED
- Drug Type
- Therapeutic
- Forensic Classification
- PHARMACY ONLY MEDICINES
- Dosage Form
- SYRUP
- Dosage
- <p><strong>Dosage:</strong><br>
Oral administration</p>
<table class="borderless-100">
<tbody>
<tr>
<td>Tablet :</td>
<td>Adults and children 12 years and older<br></td>
<td>: 1 tablet three times daily<br></td>
</tr>
<tr>
<td>Syrup :</td>
<td>Adults and children over 12 years<br></td>
<td>: 10ml three times daily<br></td>
</tr>
<tr>
<td><br></td>
<td>Children 6 to 12 years<br></td>
<td>: 5ml three times daily<br></td>
</tr>
<tr>
<td><br></td>
<td>Children 2 to 5 years<br></td>
<td>: 2.5ml three times daily<br></td>
</tr>
</tbody>
</table>
<p>Warning: Not recommended for children below 2 years. Use with caution and on doctor’s/ pharmacist’s advice in children 2 to 6 years of age.</p>
- Route Of Administration
- ORAL
- Indication Info
- <p><strong>Indications:</strong><br>
It is indicated in nasal and respiratory congestion, common cold, acute sinusitis, and allergic rhinitis.</p>
- Contraindications
- <p><strong>Contraindications:</strong><br>
The combination of triprolidine and pseudoephedrine is contraindicated under the following condition:</p>
<ol class="alphaparen">
<li>Hypersensitivity to pseudoephedrine or sympathomimetic amines</li>
<li>Patients taking MAO inhibitors</li>
<li>Severe hypertension</li>
<li>Severe coronary artery disease</li>
</ol>
- Atc Code
- R01BA52
- Atc Item Name
- pseudoephedrine, combinations
- Pharma Manufacturer Name
- SUNWARD PHARMACEUTICAL PRIVATE LIMITED
- Company Detail Path
- /organization/sunward-pharmaceutical-private-limited
